logo
logo
CNC stock ticker logo

Centene Corporation

NYSE•CNC
CEO: Ms. Sarah M. London
セクター: Healthcare
業種: Medical - Healthcare Plans
上場日: 2001-12-13
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
連絡先情報
Centene Plaza, 7700 Forsyth Boulevard, Saint Louis, MO, 63105, United States
314-725-4477
www.centene.com
時価総額
$18.48B
PER (TTM)
-2.8
25.3
配当利回り
--
52週高値
$64.15
52週安値
$25.08
52週レンジ
32%
順位24Top 10.8%
5.7
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 5.7 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q4 2025 データ

売上高

$49.73B+0.00%
直近4四半期の推移

EPS

-$2.24+0.00%
直近4四半期の推移

フリーCF

$224.00M+0.00%
直近4四半期の推移

2025 Annual 決算ハイライト

主なハイライト

Total Revenue Growth Total revenues reached $194.8 B, a 19% increase, driven by PDP yield, Marketplace growth, and premium tax revenue.
Operating Cash Flow Surge Operating cash flows were $5.1 B, a massive increase from $154 M in 2024, reflecting improved rebate timing.
Medicare Segment Expansion Medicare revenues grew 62% to $37.210 B, primarily driven by increased PDP premium yield and IRA changes.
Improved Expense Ratios SG&A expense ratio improved to 7.4% for 2025, down from 8.5% in 2024, showing cost discipline.

リスク要因

Massive Goodwill Impairment Recorded $7.311 B total impairment charges, including $6.7 B goodwill impairment due to OBBBA and stock price decline.
HBR Deterioration Health Benefits Ratio rose to 91.9% from 88.3%, driven by lower Marketplace risk adjustment revenue.
Medicaid Membership Decline Total membership fell 3% to 27.6 M, primarily due to ongoing Medicaid redeterminations following the PHE expiration.
Commercial Margin Pressure Commercial segment gross margin dropped 33% due to lower estimated risk adjustment revenue and increased medical costs.

見通し

Divestiture Completion Signed agreement to divest remaining Magellan Health businesses in December 2025, streamlining portfolio focus on core managed care.
2026 Rate Adjustments Completed refiling 2026 Marketplace rates to reflect higher projected morbidity baseline and corrective pricing actions.
Future Capital Flow Expecting net dividends of approximately $1.2 B from regulated subsidiaries during 2026 to fund capital expenditures.
D-SNP Integration Focus Continuing enterprise focus on D-SNP opportunity ahead of 2030 mandate for integrated dual-eligible care alignment.

同業比較

売上高 (TTM)

CNC stock ticker logoCNC
$194.78B
+19.4%
MOH stock ticker logoMOH
$45.43B
+11.7%
FMS stock ticker logoFMS
$22.15B
+1.5%

粗利益率 (最新四半期)

RPRX stock ticker logoRPRX
100.0%
+0.0pp
GMAB stock ticker logoGMAB
92.3%
-0.7pp
INCY stock ticker logoINCY
90.9%
+1.8pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
UTHR$25.31B19.219.3%0.0%
RPRX$20.86B27.311.9%45.6%
ILMN$20.22B23.834.9%38.4%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
2.2%
緩やかな成長
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
100%
優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年4月23日
|
EPS:-
|
売上高:-
財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書
直近12ヶ月
データなし